Syneron Medical Ltd. (ELOS) Shares are Up 3.39%

Syneron Medical Ltd. (ELOS) has been under a strong bear grip, hence the stock is down -6.62% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 3.34% in the past 1 week. The stock has risen by 3.39% in the past week indicating that the buyers are active at lower levels, but the stock is down -5.65% in the past 4 weeks.

The stock has recorded a 20-day Moving Average of 1.51% and the 50-Day Moving Average is 3.52%. Syneron Medical Ltd. (NASDAQ:ELOS): stock turned positive on Friday. Though the stock opened at $6.87, the bulls momentum made the stock top out at $7.08 level for the day. The stock recorded a low of $6.79 and closed the trading day at $7.01, in the green by 1.45%. The total traded volume for the day was 595,653. The stock had closed at $6.91 in the previous days trading.


Institutional Investors own 74.36% of Syneron Medical Ltd. shares. Also, In the latest statement by the brokerage house, Leerink Swann downgrades its outlook on Syneron Medical Ltd. (NASDAQ:ELOS). The current rating of the shares is Market Perform, according to the research report released by the firm. Previously, the company had a rating of Outperform. The rating by the firm was issued on August 5, 2016.

Syneron Medical Ltd. is engaged in manufacture, research, development, marketing and sales of advanced equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company designs, develops and markets aesthetic medical products based on its various technologies, including Electro-Optical Synergy (ELOS) technology to provide aesthetic medical treatments. The Companys products targets an array of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skins appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis and topical skin brightening products.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.